Search earnings tickers

MRK

2024Q3BMO

Merck & Company Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-10-31 · Fiscal end 2024-09-30 · Features as of 2024-10-30

← Earnings history

Street

Consensus EPS1.57

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.0%

IV front—

P/C full—

P/C front—

Features as of2024-10-30

Run-up

Close—

Ret 5d-1.5%

Ret 10d-5.1%

Ret 20d-6.5%

Ret 30d-11.6%

Print

Actual EPS

1.57—

Estimated EPS1.57

Actual revenue

16.7B

Surprise %0.0%

Beat / miss—

Beat streak 40

Beat streak 80

Reaction

1-day stock reaction+1.4%

Implied vs actual

Implied 2.0%Actual 3.7%

Gap reaction-3.7%

Day result-2.4%

Next-day upYes

Realized / IV1.84×

Post tape

Post 5d-1.1%

Post 10d-3.9%

Post volume17.4M

Vol ×10d1.79×

Vol ×20d1.89×

Post range4.6%

MRK

Pre-Earnings Data